Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

SLIM LIVER was the first clinical trial to test semaglutide as a treatment for MASLD in people living with HIV. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a common and ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

By analyzing genes encoding B-cell and T-cell receptors, the model could screen for conditions like HIV, type 1 diabetes, and ...

Blood cells and immune cells are made in the bone marrow ... treatable conditions such as HIV infection and herpes. They also include often deadly illnesses such as rabies and Ebola. Depending on the ...

Unlike other blood types, people with Rhnull blood have no Rh antigens on their red blood cells. Healthcare professionals classify blood type according to the presence or absence of antigens ...